ScienceDaily: Top Health News

Researchers have discovered one of the causes of the multi-drug resistance of some tumors, and a potential strategy to overcome it. This new 'weak spot' can be exploited using existing drugs that kill tumor cells by activating their stress responses.

Vaccination against COVID-19 had no impact on the health of placentas in pregnant women, according to new research. The findings further emphasize the safety of vaccination during pregnancy for babies and pregnant women, the investigators note.

This monoclonal antibody cocktail is deliverable via a nasal dose, and it is also effective against SARS, MERS and several coronavirus cold viruses. The antibodies are engineered for long-acting effectiveness, potentially lasting a year or more when used.

An international collaboration of clinicians has identified new clinical symptoms in people infected with monkeypox in the largest case study series to date. Their findings will improve future diagnosis, help to slow the spread of infection and help the international community prioritise the limited global supply of monkeypox vaccines and treatments to communities most at risk.

For a glimpse into the future of SARS-CoV-2 immunity, scientists are investigating how the immune system builds its defenses against common cold coronaviruses (CCCs).

Mycobacterium tuberculosis, the causative agent of tuberculosis, remains the leading cause of infectious disease worldwide, affecting approximately a quarter of the globe's population. Treatment of infections is problematic due to the emergence of drug-resistant strains; however, an expert in antibiotic resistance is leading research on new potential therapeutic treatments for the disease.

Patients are 20% less likely to die of sepsis because a new AI system catches symptoms hours earlier than traditional methods, an extensive hospital study demonstrates. The system scours medical records and clinical notes to identify patients at risk of life-threatening complications.

Telling a child about their mother's risk of hereditary breast and ovarian cancer does not adversely influence the offspring's lifestyle or quality of life in the long term, according to a new study.

Despite professional guidelines recommending early serious illness conversations for all patients with advanced cancer, many times these conversations occur, late or not at all. A collaborative research initiative shows promise in improving patient-clinician communication by increasing the conduct and documentation of these important conversations in two medical oncology clinics.